REATA PHARMACEUTICALS INC Deferred Revenue (Non-Current)
REATA PHARMACEUTICALS INC had Deferred Revenue (Non-Current) of $211.13 million as of 2018-03-31, per its 10-Q filed 2018-05-08.
Discontinued › Balance Sheet › Liabilities › Liabilities, Noncurrent › Liabilities, Other than Long-Term Debt, Noncurrent › Deferred Revenue, Noncurrent
us-gaap:DeferredRevenueNoncurrent · last filed 2018-05-08
- 2018-03-31: Deferred Revenue, Noncurrent $211.13M.
- 2017-12-31: Deferred Revenue, Noncurrent $216.25M.
- 2017-09-30: Deferred Revenue, Noncurrent $223.36M.
- 2017-06-30: Deferred Revenue, Noncurrent $230.46M.
| Period end | Deferred Revenue, Noncurrent |
|---|---|
| 2018-03-31 | $211.13M 10-Q · filed 2018-05-08 |
| 2017-12-31 | $216.25M 10-Q · filed 2018-05-08 |
| 2017-09-30 | $223.36M 10-Q · filed 2017-11-13 |
| 2017-06-30 | $230.46M 10-Q · filed 2017-08-14 |
| 2017-03-31 | $237.49M 10-Q · filed 2017-05-10 |
| 2016-12-31 | $244.44M 10-K · filed 2018-03-02 |
| 2016-09-30 | $253.95M 10-Q · filed 2016-11-14 |
| 2016-06-30 | $266.45M 10-Q · filed 2016-08-11 |
| 2015-12-31 | $291.04M 10-K · filed 2017-03-03 |